SE408426B - Sett att framstella d-homo-20-ketopregnaner - Google Patents

Sett att framstella d-homo-20-ketopregnaner

Info

Publication number
SE408426B
SE408426B SE7414960A SE7414960A SE408426B SE 408426 B SE408426 B SE 408426B SE 7414960 A SE7414960 A SE 7414960A SE 7414960 A SE7414960 A SE 7414960A SE 408426 B SE408426 B SE 408426B
Authority
SE
Sweden
Prior art keywords
calculators
keto
homo
way
make
Prior art date
Application number
SE7414960A
Other languages
English (en)
Swedish (sv)
Other versions
SE7414960L (enEXAMPLES
Inventor
U Kerb
R Wiechert
K Kieslich
K Petzoldt
H Wachtel
D Palenschat
R Horowski
G Paschelke
W Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7414960L publication Critical patent/SE7414960L/xx
Publication of SE408426B publication Critical patent/SE408426B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
SE7414960A 1973-11-30 1974-11-28 Sett att framstella d-homo-20-ketopregnaner SE408426B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (2)

Publication Number Publication Date
SE7414960L SE7414960L (enEXAMPLES) 1975-06-02
SE408426B true SE408426B (sv) 1979-06-11

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414960A SE408426B (sv) 1973-11-30 1974-11-28 Sett att framstella d-homo-20-ketopregnaner

Country Status (14)

Country Link
US (1) US4045574A (enEXAMPLES)
JP (1) JPS5084561A (enEXAMPLES)
AT (1) AT347611B (enEXAMPLES)
CA (1) CA1030522A (enEXAMPLES)
CH (1) CH618183A5 (enEXAMPLES)
DD (1) DD115659A5 (enEXAMPLES)
DK (1) DK134348C (enEXAMPLES)
ES (1) ES432106A1 (enEXAMPLES)
FR (1) FR2253512B1 (enEXAMPLES)
GB (1) GB1494097A (enEXAMPLES)
IE (1) IE40423B1 (enEXAMPLES)
IL (1) IL46153A (enEXAMPLES)
NL (1) NL7415577A (enEXAMPLES)
SE (1) SE408426B (enEXAMPLES)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
CA2495412A1 (en) * 2002-08-16 2004-02-26 Pharmacia & Upjohn Company 5 androsten-3.beta.-ol steroid intermediates and processes for their preparation
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
RU2700264C2 (ru) 2013-04-17 2019-09-16 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
EP2986623B1 (en) 2013-04-17 2018-11-07 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
ES2848823T3 (es) 2013-08-23 2021-08-12 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SMT202000414T1 (it) 2014-10-16 2020-09-10 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
JP6745274B2 (ja) 2015-01-26 2020-08-26 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3481844B1 (en) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
EP3481845B1 (en) 2016-07-11 2023-09-13 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
US20220315621A1 (en) * 2017-12-22 2022-10-06 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
US20230322846A9 (en) 2018-12-05 2023-10-12 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use
CN116059215B (zh) 2019-01-08 2025-10-03 成都康弘药业集团股份有限公司 甾体类化合物、用途及其制备方法
CA3139554A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
AU2020304679A1 (en) * 2019-06-27 2022-01-20 Sage Therapeutics, Inc. Compounds for treating CNS disorders
US20230085354A1 (en) * 2019-06-27 2023-03-16 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
DK604174A (enEXAMPLES) 1975-07-28
CH618183A5 (enEXAMPLES) 1980-07-15
FR2253512A1 (enEXAMPLES) 1975-07-04
DK134348B (da) 1976-10-25
IL46153A (en) 1979-01-31
IL46153A0 (en) 1975-02-10
AU7586774A (en) 1976-06-03
NL7415577A (nl) 1975-06-03
US4045574A (en) 1977-08-30
AT347611B (de) 1979-01-10
ATA950774A (de) 1978-05-15
SE7414960L (enEXAMPLES) 1975-06-02
JPS5084561A (enEXAMPLES) 1975-07-08
FR2253512B1 (enEXAMPLES) 1978-02-03
IE40423B1 (en) 1979-05-23
GB1494097A (en) 1977-12-07
DK134348C (da) 1977-03-21
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
CA1030522A (en) 1978-05-02
DD115659A5 (enEXAMPLES) 1975-10-12

Similar Documents

Publication Publication Date Title
SE408426B (sv) Sett att framstella d-homo-20-ketopregnaner
IT1019129B (it) Calcolatrice elettronica
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE411545B (sv) Sett att framstella chalkonetrar.
IT980896B (it) Perfezionamenti alle calcolatri ci elettroniche
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE421371B (sv) Sett att framstella leverkorv
SE387250B (sv) Sett att separera flytande fretande substansblandningar
SE382215B (sv) Sett att framstella kromanderivat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE401176B (sv) Sett att framstella nya hypokalcemiskt verksamma dotriakontapeptidamider
SE418205B (sv) Sett att framstella flerskiktskartong
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE425850B (sv) Sett att framstella abietamidderivat.
SE415653B (sv) Sett att framstella cykloalkylfenoxikarboxylsyraderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE397679B (sv) Sett att framstella kinazolinonderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE417830B (sv) Sett att framstella vissa sulfonylmetylsubstituerade bicykloalkanoner
SE388142B (sv) Sett att gjuta lettmetallgot